Suppr超能文献

平衡麻醉中阿片类药物的药代动力学-药效学关系

Pharmacokinetic-pharmacodynamic relationships for opioids in balanced anaesthesia.

作者信息

Lemmens H J

机构信息

Department of Anesthesia, Stanford University School of Medicine, California, USA.

出版信息

Clin Pharmacokinet. 1995 Oct;29(4):231-42. doi: 10.2165/00003088-199529040-00003.

Abstract

The pure mu-receptor opioid agonists fentanyl, sufentanil and alfentanil are commonly used to provide the specific anti-nociceptive component of a balanced anaesthesia technique. Trefentanil and remifentanil are new opioids with a very short duration of action. Remifentanil has an ester structure and is very rapidly metabolised by blood and tissue esterases. Different perioperative stimuli require different plasma concentrations to suppress responses of the patient. The ability of the anaesthesiologist to select a precise dosage scheme for the individual patient is impeded by the large interindividual pharmacokinetic and pharmacodynamic variability. In addition, the combination of opioids and other drugs used to produce the desired components of balanced anaesthesia may exert additive, synergistic or antagonistic effects. Knowledge of factors influencing the pharmacokinetics and pharmacodynamics is still fragmentary and often controversial. Consequently, the opioid dose needs to be adjusted according to the responses of the patient during surgery to ensure adequate anaesthesia and rapid recovery. The duration of action is not predicted by the elimination half-life alone. The decline in effect-site concentration is dependent on the complex entity of infusion duration, and pharmacokinetic and pharmacodynamic parameters. Computer simulations of infusions of varying duration have been extremely useful when selecting an opioid for a specific clinical scenario on a rational basis. Traditionally, opioids are still administered by intermittent bolus injections. A disadvantage of this method of administration is that plasma concentrations fluctuate above and below the level required for adequate anaesthesia. Computer-assisted infusion pumps make it possible to target a particular drug concentration in plasma and to maintain or change this concentration as needed. This technique provides more stable anaesthesia and a more rapid recovery of the patient.

摘要

纯μ受体阿片类激动剂芬太尼、舒芬太尼和阿芬太尼通常用于提供平衡麻醉技术的特定抗伤害感受成分。瑞芬太尼和替瑞芬太尼是作用持续时间非常短的新型阿片类药物。瑞芬太尼具有酯结构,可被血液和组织酯酶非常迅速地代谢。不同的围手术期刺激需要不同的血浆浓度来抑制患者的反应。个体间药代动力学和药效学的巨大变异性阻碍了麻醉医生为个体患者选择精确给药方案的能力。此外,用于产生平衡麻醉所需成分的阿片类药物与其他药物的组合可能会产生相加、协同或拮抗作用。影响药代动力学和药效学的因素的知识仍然支离破碎,且常常存在争议。因此,需要根据患者在手术期间的反应调整阿片类药物剂量,以确保充分麻醉和快速恢复。作用持续时间不能仅由消除半衰期预测。效应部位浓度的下降取决于输注持续时间、药代动力学和药效学参数的复杂组合。在基于合理基础为特定临床情况选择阿片类药物时,不同持续时间输注的计算机模拟非常有用。传统上,阿片类药物仍通过间歇性推注给药。这种给药方法的一个缺点是血浆浓度在充分麻醉所需水平上下波动。计算机辅助输注泵使在血浆中靶向特定药物浓度并根据需要维持或改变该浓度成为可能。该技术可提供更稳定的麻醉和患者更快的恢复。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验